Consent

This site uses third party services that need your consent. Learn more

Skip to content

MPS VI Maroteaux Lamy

Share:

On this page you can find general information about the condition, latest news, updates and stories and a list of relevant resources and events.

What is MPS VI?

MPS VI, known as Maroteaux-Lamy disease, is one of the mucopolysaccharide storage diseases. MPS VI was first identified by Dr Maroteaux and Dr Lamy in 1963.

Mucopolysaccharides are long chains of sugar molecules used in the building of bones, cartilage, skin, tendons and many other tissues in the body. In the course of normal life there is a continuous recycling process of building new mucopolysaccharides and breaking down old ones. The breakdown and recycling process requires a series of special biochemical tools called enzymes.

People with MPS VI are missing or are low in an enzyme called N-acetylgalactosamine-4-sulfatase, which is essential in breaking down mucopolysaccharides dermatan sulphate. When dermatan sulphate is not completely broken down it remains stored in the body and the symptoms of MPS VI occur.

Frequently asked questions

Mucopolysaccharides are long chains of sugar molecules used in the building of bones, cartilage, skin, tendons and many other tissues in the body. “Muco” refers to the thick jelly-like consistency of the sugar molecules, “poly” means many, and “saccharide” is a general term for the sugar part of the molecule. In the course of normal life there is a continuous recycling process of building new mucopolysaccharides and breaking down old ones. The breakdown and recycling process requires a series of special biochemical tools called enzymes.

People with MPS VI are missing or are low in an enzyme called N-acetylgalactosamine-4-sulfatase, which is essential in breaking down mucopolysaccharides dermatan sulphate. When dermatan sulphate is not completely broken down it remains stored in the body. The symptoms of MPS VI occur when there is a build-up of dermatan sulphate in the tissues in the body. Babies may show little sign of the disease but as more and more cells build up with partially broken down dermatan sulphate, symptoms start to appear.

Latest resources

Oliver's story

I was diagnosed with MPS VI in 1999 when I was just 4 years old. At this time there was no cure or treatment to help slow down the progression of the disease but with the research largely funded by the MPS Society, eventually a treatment was developed called enzyme replacement therapy (ERT).

Latest news and blogs

Your stories

Need someone to talk to?

Our support includes an active listening service and telephone helpline.

Get support